The US FDA is proposing a switch to annual COVID vaccination shots | Aici


Jan 23 (Reuters) – The U.S. health regulator on Monday suggested using one dose of the latest COVID-19 shot annually for healthy adults, similar to the flu vaccine, as it aims to streamline the country’s current COVID vaccine strategy. .

The Food and Drug Administration’s proposal was outlined in its briefing papers ahead of a meeting of the foreign advisory panel on Thursday.

It also asked the panel to consider the use of two annual shots of the COVID-19 vaccine in some young children, as well as in older adults and people who are immunocompromised.

The administrator also sought input from his advisers on the need for regular selection of vaccine variants, similar to how flu vaccines are changed every year.

The agency’s proposal was in line with expectations, following its announcement of its intention to renew last month.

The Biden administration has also been planning a booster vaccination campaign every fall.

The agency anticipates that simplifying the design of the COVID vaccine and annual vaccination schedules may result in less complex vaccinations, fewer vaccine administration errors and less difficult communication, which may lead to improved vaccine coverage rates.

Currently, most people in the United States need to first receive two doses of the primary COVID vaccine spaced 3-4 weeks apart, depending on the vaccine, followed by a booster several months later.

If the panel votes on the proposal, Pfizer Inc and Moderna Inc’s vaccines, which target both Omicron and the original variant, will be used for all doses of the COVID vaccine, not just as boosters.

The FDA’s proposal follows support from the European regulator last month for the use of a bivalent COVID vaccine in primary vaccination. (Reporting by Leroy Leo in Bengaluru; Editing by Shailesh Kuber)



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *